Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Voorhees, MD
University of North Carolina, Chapel Hill
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
336 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Delaware Clinical and Laboratory Physicians Pa
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Nanticoke Memorial Hospital
Seaford, Delaware, United States
- Christiana Care Health System-Wilmington Hospital
Wilmington, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Medical Center
Coeur d'Alene, Idaho, United States
- Walter Knox Memorial Hospital
Emmett, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Fruitland
Fruitland, Idaho, United States
- Idaho Urologic Institute-Meridian
Meridian, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Medical Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Nampa
Nampa, Idaho, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
- Kootenai Cancer Clinic
Sandpoint, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute-Twin Falls
Twin Falls, Idaho, United States
- Rush - Copley Medical Center
Aurora, Illinois, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Saint Joseph Medical Center
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Memorial Hospital of Carbondale
Carbondale, Illinois, United States
- Sih Cancer Institute
Carterville, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2014
- Primary completion
- 1 Dec 2021
- Completion
- —
- Last update posted
- 1 Dec 2023
- Registered enrollment
- 118
- Registry id
- NCT02004275
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.